-
1دورية أكاديمية
المؤلفون: Luc Colas, MD, PhD, Linh Bui, MD, Clarisse Kerleau, Mohamed Lemdani, PhD, Karine Autain-Renaudin, MD, PhD, Antoine Magnan, MD, Magali Giral, MD, PhD, Sophie Brouard, VMD, PhD
المصدر: EBioMedicine, Vol 73, Iss , Pp 103645- (2021)
مصطلحات موضوعية: Eosinophilia, Donor-specific antibodies (DSAs), Graft rejection, Type 2 inflammation, Medicine, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2352396421004382Test; https://doaj.org/toc/2352-3964Test
-
2دورية أكاديمية
المؤلفون: Luc Colas, Dorian Hassoun, Antoine Magnan
المصدر: Frontiers in Medicine, Vol 7 (2020)
مصطلحات موضوعية: asthma, type 2 inflammation, biologics, system medicine, 4P medicine, omics sciences, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/article/10.3389/fmed.2020.00098/fullTest; https://doaj.org/toc/2296-858XTest
-
3دورية أكاديمية
المؤلفون: Colas, Luc, Bui, Linh, Kerleau, Clarisse, Lemdani, Mohamed Salim, Autain-Renaudin, Karine, Magnan, Antoine O., Giral, Magali, Brouard, Sophie
المساهمون: Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Centre de Recherche en Transplantation et Immunologie (U1064 Inserm - CRTI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Centre Hospitalier de Mouscron, Université de Nantes (UN), Université de Lille, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Virologie et Immunologie Moléculaires (VIM (UR 0892)), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), ANR-17-CE17-0008, ANR-17-RHUS-0010, ANR-18-CE17-0019, ANR-10-IBHU-005, Agence Nationale de la Recherche, ANR, Horizon 2020: 754995, Centre Hospitalier Universitaire de Nantes, CHU de Nantes, Conseil Régional des Pays de la Loire, We thank the patients and their families, whose trust, support, and cooperation were essential for the collection of the data used in this study. Luc Colas is under a Cifre contract with GlaxoSmithKline and financially supported by Institut de Recherche en Sant? Respiratoire des Pays de la Loire (IRSRPL). This work was performed in the context of the IHU-Cesti project (ANR-10-IBHU-005), the DHU Oncogreffe, the ANR project PRELUD (ANR-18-CE17-0019), the ANR project BIKET (ANR-17-CE17-0008) and the ANR project KTD-innov (ANR-17-RHUS-0010) thanks to French government financial support managed by the National Research Agency. The IHU-Cesti project was also supported by Nantes M?tropole and R?gion Pays de la Loire. The laboratory received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 754995 and from CHU de Nantes thanks to ?l'Appel d'Offre Interne? for the ICART project, Luc Colas is under a Cifre contract with GlaxoSmithKline and financially supported by Institut de Recherche en Santé Respiratoire des Pays de la Loire (IRSRPL). This work was performed in the context of the IHU-Cesti project (ANR-10-IBHU-005), the DHU Oncogreffe, the ANR project PRELUD (ANR-18-CE17-0019), the ANR project BIKET (ANR-17-CE17-0008) and the ANR project KTD-innov (ANR-17-RHUS-0010) thanks to French government financial support managed by the National Research Agency. The IHU-Cesti project was also supported by Nantes Métropole and Région Pays de la Loire. The laboratory received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 754995 and from CHU de Nantes thanks to “l'Appel d'Offre Interne” for the ICART project, ANR-17-CE17-0008,Biket,Cellules B GZMB+, un facteur clé de l'immunité chez l'homme?(2017), ANR-17-RHUS-0010,KTD-INNOV,Kidney Transplantation Diagnostics Innovation(2017), ANR-18-CE17-0019,PRELUD,Prédiction de la dysfonction chronique du greffon après transplantation pulmonaire(2018)
المصدر: ISSN: 2352-3964 ; EBioMedicine ; https://hal.science/hal-03434924Test ; EBioMedicine, 2021, 73, pp.103645. ⟨10.1016/j.ebiom.2021.103645⟩.
مصطلحات موضوعية: Donor-specific antibodies (DSAs), Eosinophilia, Graft rejection, Type 2 inflammation, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34688031; hal-03434924; https://hal.science/hal-03434924Test; https://hal.science/hal-03434924/documentTest; https://hal.science/hal-03434924/file/main%281%29.pdfTest; PUBMED: 34688031; PUBMEDCENTRAL: PMC8536518
الإتاحة: https://doi.org/10.1016/j.ebiom.2021.103645Test
https://hal.science/hal-03434924Test
https://hal.science/hal-03434924/documentTest
https://hal.science/hal-03434924/file/main%281%29.pdfTest
النص الكامل